PMID: 19 PablosMIChuangJReiterRJOrtizGGDanielsWMSewerynekEet al
[DOI] [PMC free article] [PubMed] [Google Scholar] 60.Yang F.-C., Ingram D.A., Chen S., Zhu Y., Yuan J., Li X., Yang X., Knowles S., Horn W., Li Y., et al
Novo Nordisk and Eli Lilly turn their attention to GLP-1 effects on alcohol As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two pharma giants that are responsible for the development of the current crop of blockbuster GLP-1 drugs: Novo Nordisk and Eli Lilly
My serum iron is now 195 (range is 40-190), saturation is 76% (range is 11-50)
Research continues into other GLP-1-based drugs to assess their potential impact on Alzheimers disease